According to NCBI reports of breathing discomfort and increased risk of bronchospasm in such cases
Unlike single-pathway medications, Tirzepatides dual mechanism helps improve blood sugar control while also contributing to significant weight loss a major advantage for patients who are overweight or obese
Key questions to discuss include: Whether you meet NHS criteria for GLP-1 prescription (type 2 diabetes or obesity with complications) The evidenceor lack thereoffor GLP-1 use specifically in Hashimoto's management Potential interactions between GLP-1 medications and thyroid hormone replacement How GLP-1 therapy might affect your thyroid function monitoring schedule Alternative evidence-based approaches to managing metabolic symptoms in Hashimoto's The costs and practicalities of private prescription if NHS funding is not available Contraception requirements if you are of childbearing potential (GLP-1 medications should be avoided in pregnancy and breastfeeding) Your GP may recommend optimising your current thyroid management first , ensuring your levothyroxine dose is appropriate and that you are not over- or under-replaced
The clinical significance of biased dual GIPRAs and GLP-1RAs has not yet been assessed due to the limited existence of such clinically available drugs
Effects of vitamin E, vitamin C and polyphenols on the rate of blood pressure variation: results of two randomised controlled trials
Here are some potential benefits of switching: More and faster weight loss Better blood glucose control, especially when weight loss has plateaued Drug availability, as tirzepatide may be easier to find right now Lower cost, with tirzepatide being about $300 less per month without insurance Risks and Potential Drawbacks of Switching Switching from semaglutide to tirzepatide can come with potential risks and drawbacks beyond just the common side effects
